• LAST PRICE
    15.7550
  • TODAY'S CHANGE (%)
    Trending Up1.2550 (8.6552%)
  • Bid / Lots
    15.2600/ 2
  • Ask / Lots
    15.7000/ 1
  • Open / Previous Close
    15.0000 / 14.5000
  • Day Range
    Low 14.5409
    High 19.3700
  • 52 Week Range
    Low 8.5000
    High 19.3700
  • Volume
    85,846

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 14.5
TimeVolumeIZTC
09:32 ET335015
09:35 ET61014.5409
09:42 ET158215.06
09:44 ET215415.3909
09:46 ET390015.27
09:48 ET320015.75
09:50 ET342116.25
09:51 ET584817.93
09:53 ET169018
10:00 ET302418.44
10:02 ET294618.375
10:04 ET50018.07
10:06 ET313918
10:08 ET586017.65
10:09 ET30017.45
10:11 ET30017.43
10:13 ET253817.375
10:15 ET36916.767
10:24 ET22018.24
10:26 ET42018.24
10:27 ET20018.079
10:31 ET25018.16
10:40 ET10017.7595
10:49 ET85017.9638
10:54 ET143417.49
10:56 ET40017.2
10:58 ET10017.47
11:02 ET10017
11:05 ET30917
11:07 ET10016.925
11:12 ET10017
11:18 ET30016.53
11:30 ET25716.6
11:34 ET50016.75
11:36 ET20016.5001
11:45 ET20016.5
11:50 ET65016.25
11:52 ET10016.5
11:57 ET61116.26
11:59 ET60016
12:01 ET49616.5
12:06 ET110016.135
12:10 ET100016.3615
12:14 ET50016.3998
12:17 ET74916.5
12:19 ET204816.85
12:28 ET83216.2499
12:30 ET70015.8862
12:33 ET120015.27
12:35 ET320015.6132
12:37 ET319415.25
12:39 ET40015.3069
12:42 ET30015.438
12:55 ET10015.3
01:02 ET20015.5
01:09 ET411015.3051
01:15 ET40015.5204
01:18 ET88615.6677
01:22 ET80415.755
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesIZTC
Invizyne Technologies Inc
117.8M
-25.0x
---
United StatesOTLK
Outlook Therapeutics Inc
121.4M
-0.6x
---
United StatesVTYX
Ventyx Biosciences Inc
122.3M
-0.8x
---
United StatesVIGL
Vigil Neuroscience Inc
122.6M
-1.5x
---
United StatesCNTX
Context Therapeutics Inc
112.5M
-1.5x
---
United StatesPYXS
Pyxis Oncology Inc
124.9M
-1.9x
---
As of 2024-11-22

Company Information

Invizyne Technologies, Inc. is a biotechnology, pre-revenue, development stage company. The Company's cell-free technology expands its ability to perform enzyme-based conversions, guiding towards sustainable biomanufacturing. The Company is primarily engaged in the development of the SimplePath platform. Its SimplePath platform consists of a series of enzyme based biomanufacturing systems that leverage natural processes to perform complex chemical conversions that convert a starting material into a desired end-product. Each SimplePath system is composed of one or more modules which consist of one or more enzymes that work together to perform a defined biocatalytic conversion. It can provide solutions for natural ingredients (cannabinoids, flavor enhancers for food and beverage products, fragrances, nutraceuticals, organic compounds), pharmaceuticals (natural products with therapeutic properties) and chemicals (commodity chemicals, specialty chemicals, biofuels).

Contact Information

Headquarters
750 Royal Oaks Drive, Suite 10MONROVIA, CA, United States 91016
Phone
626-415-1488
Fax
---

Executives

Chairman of the Board, President
Mohammad Hayat
Chief Executive Officer
Michael Heltzen
Vice President - Finance
Fouad Nawaz
Vice President - Research
Tyler Korman
Vice President - Development
Paul Opgenorth

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$117.8M
Revenue (TTM)
$0.00
Shares Outstanding
8.1M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-0.63
Book Value
$-0.05
P/E Ratio
-25.0x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.